Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free survival in CSCC in the adjuvant setting, reducing the risk of ...
Cancer Research UK surveyed 6,844 people via YouGov in the UK to understand what prevented people getting help.
J&J's $3.05B move for Halda adds targeted oral cancer therapies and expands its prostate cancer pipeline amid rising pharma M&A.
"Most ulcers are nothing to worry about," Dr Bozic added. "But if one refuses to heal, don't wait. Getting it checked could ...
People who suffer from mouth ulcers are being given a serious health alert. Mouth ulcers, also known as canker sores or ...